0001209191-23-056086.txt : 20231120
0001209191-23-056086.hdr.sgml : 20231120
20231120165548
ACCESSION NUMBER: 0001209191-23-056086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231117
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rhode Peter
CENTRAL INDEX KEY: 0001866276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40591
FILM NUMBER: 231423420
MAIL ADDRESS:
STREET 1: C/O HCW BIOLOGICS, INC.
STREET 2: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCW Biologics Inc.
CENTRAL INDEX KEY: 0001828673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825024477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 954-842-2024
MAIL ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-17
0
0001828673
HCW Biologics Inc.
HCWB
0001866276
Rhode Peter
C/O HCW BIOLOGICS INC
2929 N. COMMERCE PARKWAY
MIRAMAR
FL
33025
0
1
0
0
See Remarks
0
Common Stock
2023-11-17
4
M
0
15000
0.14
A
63500
D
Stock Option Grant (Right to Buy)
0.14
2023-11-17
4
M
0
15000
0.00
D
2029-12-19
Common Stock
15000
36427
D
These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant vested on May 30, 2022; and 35% of the total shares subject to the stock option grant vested on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date.
Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.
/s/ Nicole Valdivieso, as Attorney-in-Fact for Peter Rhode
2023-11-20